Dublin, May 01, 2020 (GLOBE NEWSWIRE) -- The "Global Ophthalmology Therapeutics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The author has been monitoring the global ophthalmology therapeutics market and it is poised to grow by USD 10.42 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The reports on global ophthalmology therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in prevalence of eye diseases. In addition, development of novel drug delivery systems is anticipated to boost the growth of the global ophthalmology therapeutics market as well.

Key Trends for global ophthalmology therapeutics market growth
This study identifies development of novel drug delivery systems as the prime reasons driving the global ophthalmology therapeutics market growth during the next few years.

Prominent vendors in global ophthalmology therapeutics market
We provide a detailed analysis of around 25 vendors operating in the global ophthalmology therapeutics market, including some of the vendors such as AbbVie Inc., Aerie Pharmaceuticals Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd. and Teva Pharmaceutical Industries Ltd.

The study was conducted using an objective combination of primary and secondary information including inputs from key icipants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Key Topics Covered:

01: EXECUTIVE SUMMARY

02: SCOPE OF THE REPORT

• Preface
• Currency conversion rates for US$

03: MARKET LANDSCAPE

• Market ecosystem
• Parent market
• Market characteristics
• Value chain analysis
• Market segmentation analysis

04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook

05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

06: MARKET SEGMENTATION BY PRODUCT

• Market segmentation by product
• Comparison by product
• Retinal disorder therapeutics - Market size and forecast 2019-2024
• Glaucoma therapeutics - Market size and forecast 2019-2024
• Dry eye disease therapeutics - Market size and forecast 2019-2024
• Eye infections and inflammation therapeutics -
• Market size and forecast 2019-2024
• Other therapeutics - Market size and forecast 2019-2024
• Market opportunity by product

07: CUSTOMER LANDSCAPE

08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

09: DECISION FRAMEWORK

10: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

11: MARKET TRENDS

• Development of novel drug delivery systems
• Increase in strategic alliances
• Increasing research on gene therapy products

12: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• AbbVie Inc.
• Aerie Pharmaceuticals Inc.
• Bayer AG
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Santen Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.

14: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/r/4gf9o1

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900